Efavirenz (EFV) in HIV-Infected and HIV/Tuberculosis (TB) Coinfected Children

The requested reference [b1f7a6e4f230db1e02e5fd1353224ca66c367e1d] no longer exists in our database. It has been replaced by the current reference: [114569aa129338f3fb4267b373f44cac317a0414]

Authors
Category Primary study
Registry of TrialsClinicalTrials.gov
Year 2008
Efavirenz (EFV) is an anti-HIV medicine that is commonly used to treat HIV infection in adults and children older than 3 years of age. This study is being conducted to look at the safety of EFV, blood levels of EFV, genetic factors that may affect blood levels of EFV, and how easy it is for infants and young children to take and tolerate EFV. This information will help recommend the best doses of EFV for children younger than 3 years of age.
Epistemonikos ID: 453b9965cf2acb9cc2ff9a5cf7d8b0099188aa49
First added on: Dec 01, 2021